Ardelyx (ARDX) Firmly Above Resistance.
Were not traders and we don't do technical analysis, but we could see this coming from a mile away. Next stop $9.00...
Adding Cardiol Therapeutics (CRDL) $0.59 to Watch List.
Adding to 2023 Biotech Stock Review Watch List. We Think This One Has Legs.
Starting Due Diligence...
Citius Pharma (CTXR) to Merge Subsidiary, with Publicly Traded SPAC TenX Keane (TENK). Shares...
We Would Define This as Huge News..
Citius Pharma would receive 67.5...
Citius Pharmaceuticals Completes Enrollment in Phase 2b Study of Halo-Lido for the Prescription Treatment...
Topline Results anticipated by the end of Q2 2023
CRANFORD, N.J. , April 3, 2023 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or...
Adding Pressure BioSciences (PBIO) $0.80 to Watch List.
Long Time Coming, Pressure Bio Reaches Turning Point. Science Finally Meets Revenues.
Photo Ric Schumacher CEO
And We Have a $26.4 Billion Winning Trifecta!
THREE PREVIOUS WINNERS*
Immunomedics (IMMU) $3 to $87 up 2,800%, a gain of $20.7 billion. Acquired...
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating...
A pre-clinical observational study published in Drug Development & Delivery found that more than 80% of patients experienced relief within minutes of...
Report: Is Psycheceutical BioScience (BWVI) One of the Most Important Companies in the Psychedelic...
Initiating Coverage on Psycheceutical BioScience (BWVI).
"Imagine Applying a Psychedelic Topically, Receiving the Benefits...
Topical PTSD Drug Poised for Human Trials.
In a press release issued on February 15, Psycheceutical Bioscience (BWVI), in partnership with iNGENū, a contract research organization in the cannabinoid...
With Help of Sanofi (SNY), Dario Health (DRIO) Builds Scientific Case for Its Diabetes...
We always find it Interesting when a Company with a $130 billion market cap (Sanofi: SNY), teams up with a Company...